GRIN Therapeutics to Present Data from Honeycomb Trial of Investigational Radiprodil in GRIN-Related Neurodevelopmental Disorder
Hand-out
Press Releases
GRIN Therapeutics Inc.  
November 21, 2024

GRIN Therapeutics to Present Data from Honeycomb Trial of Investigational Radiprodil in GRIN-Related Neurodevelopmental Disorder

Presentation at the American Epilepsy Society Annual Meeting will also highlight proposed design of planned Phase 3 study of radiprodil in children with gain-of-function variants

avatar profile Olean Times Herald

Olean Times Herald


Local & Social